Pacira (PCRX) Reports Q2 Earnings: What Key Metrics Have to Say

View all Key Company Metrics for Pacira here>>> Shares of Pacira have returned -28.5% over the past month versus the Zacks S&P 500 composite's +0.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. Pacira (PCRX) reported $178.02 million in revenue for the quarter ended June 2024, representing a year-overyear increase of 5.1%. EPS of $0.89 for the same period compares to $0.78 a year ago. The reported revenue represents ...